Nasal-Phyto Pharmaceutical is a global leading innovative drug and new dosage form pharmaceutical technology company. It is committed to building a world-class "brain science application transformation platform" to provide new treatments for a series of brain diseases. The founding team of Nasal-Phyto Pharmaceuticals comes from Hong Kong University School of Medicine, Duke University's Department of Biomedical Engineering and other internationally renowned institutions. It has built and co-built a neurotrophic drug screening platform, neurophysiological and pathological platform, intelligent targeted drug delivery platform, and nanomaterial And diagnostic technology platform. At present, the company has declared two innovative drugs and technology patents, and independently developed the world's first small animal intelligent integrated nasal drug delivery device. The exclusive patented device can realize preclinical drug efficacy research and assist new drug research and development. Prospects of domestic and foreign markets. Nasal-Phyto Pharmaceutical's biomedical engineering R & D team is developing a precision drug delivery device for clinical applications, which will provide greater adaptability and safety for patients with brain diseases in the future.